Applications of bacillus Calmette-Guerin and recombinant bacillus Calmette-Guerin in vaccine development and tumor immunotherapy

作者：Zheng Yuan qiang; Naguib Youssef W; Dong Yixuan; Shi Yan chun^*; Bou Shorgan; Cui Zhengrong

来源：Expert Review of Vaccines, 2015, 14(9): 1255-1275.

DOI：10.1586/14760584.2015.1068124

• bacterial vector
• Bacillus Calmette-Guerin
• bladder cancer
• clinical applications
• infectious disease
• recombinant BCG
• tumor
• vaccine development

Bacillus Calmette-Guerin (BCG) vaccines are attenuated live strains of Mycobacterium bovis and are among the most widely used vaccines in the world. BCG is proven to be effective in preventing severe infant meningitis and miliary tuberculosis. Intravesical instillation of BCG is also a standard treatment for non-muscle invasive bladder cancer. In the past few decades, recombinant BCG (rBCG) technology had been extensively applied to develop vaccine candidates for a variety of infectious diseases, including bacterial, viral, and parasite infections, and to improve the efficacy of BCG in bladder cancer therapy. This review is intended to show the vast applications of BCG and recombinant BCG (rBCG) in the prevention of infectious diseases and cancer immunotherapy, with a special emphasis on recent approaches and trends on both pre-clinical and clinical levels.

• 出版日期2015-9
• 单位内蒙古医科大学; 内蒙古大学